BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Larynx Cancer

Below is an extended Larynx Cancer patents listing. Click here to return to the Larynx Cancer main in depth entry.

Patents :

US Patent No.Title
6926898 Albumin fusion proteins
7074901 Isolated human vCOL16A1 polypeptide and fragments thereof
7091315 Protein HDPBQ71
7094876 Human cDNAs and proteins and uses thereof
7109030 Methods of therapy and diagnosis using insulin-like growth factor binding protein-like polypeptides and polynucleotides
7122629 Human cDNAs and proteins and uses thereof
7135463 RHoB as a suppressor of cancer cell growth, cell transformation, and metastasis
7141547 Albumin fusion proteins comprising GLP-1 polypeptides
7148215 Chemical compounds
7163797 50 human secreted proteins
7189690 Albumin fusion proteins
7074571 Serine carboxypeptidase hx (SCPhx) and compositions thereof
7067301 Methods and materials relating to novel prothrombinase-like polypeptides and polynucleotides
7053050 Preventives/remedies for proliferative organ diseases chronic arthritic diseases, hypertrophic scar or keloid
6942970 Identifying subjects suitable for topoisomerase II inhibitor treatment
6946134 Albumin fusion proteins
6951924 Antibodies against secreted protein HTEBYII
6958143 Chewing gum composition for effectively eliminating nicotine accumulated in a human body
6989262 Plasmin variants and uses thereof
6994857 Albumin fusion proteins
7005500 Human cDNAs and proteins and uses thereof
7026447 53 human secreted proteins
7028693 Smoking reduction method
7029677 Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells
7196164 Secreted protein HHTLF25
7220419 Self-assembling recombinant papillomavirus capsid proteins
7378253 Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells
7378423 Pyrimidine compound and medical use thereof
7381800 Antibodies to HBIMF63 polypeptide
7384935 Phosphate prodrugs of a farnesyl dibenzodiazepinone, processes for their production and their use as pharmaceuticals
7407755 Determining a predisposition to cancer
7407784 L-amino acid oxidase with cytotoxic activity from Aplysia punctata
7411051 Antibodies to HDPPA04 polypeptide
7411052 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
7425548 Materials and methods for immune system stimulation
7425610 Methods and materials relating to CD84-like polypeptides and polynucleotides
7368531 Human secreted proteins
7368527 HADDE71 polypeptides
7361356 Self-assembling recombinant papillomavirus capsid proteins
7238660 Albumin fusion proteins
7238667 Albumin fusion proteins
7271156 Immunostimulatory nucleic acids
7276237 Human Mob-5 (IL-24) receptors and uses thereof
7282330 Methods and apparati using single polymer analysis
7291495 .beta.-Secretase variant
7317099 Polynucleotides encoding stem cell growth factor-like polypeptides
7319141 Stem cell growth factor-like polypeptides
7354933 Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
7358355 Antibodies against human parathyroid hormone related protein
7427395 Chemotherapeutic agent-incorporated pharmaceutical preparation
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional